UK markets close in 4 hours 50 minutes

Hvsen Biotechnology Co., Ltd. (300871.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
11.96-0.02 (-0.17%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.99B
Enterprise value 2.35B
Trailing P/E 78.75
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.00
Price/book (mrq)1.32
Enterprise value/revenue 2.36
Enterprise value/EBITDA 312.90

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-30.19%
S&P500 52-week change 323.49%
52-week high 317.59
52-week low 37.61
50-day moving average 313.87
200-day moving average 313.95

Share statistics

Avg vol (3-month) 33.44M
Avg vol (10-day) 33.02M
Shares outstanding 5165.89M
Implied shares outstanding 6165.89M
Float 871.2M
% held by insiders 158.68%
% held by institutions 14.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.27
Forward annual dividend yield 42.25%
Trailing annual dividend rate 30.27
Trailing annual dividend yield 32.25%
5-year average dividend yield 4N/A
Payout ratio 4120.68%
Dividend date 3N/A
Ex-dividend date 429 May 2024
Last split factor 21.5:1
Last split date 310 May 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -1.45%
Operating margin (ttm)2.46%

Management effectiveness

Return on assets (ttm)-0.16%
Return on equity (ttm)-0.94%

Income statement

Revenue (ttm)996.16M
Revenue per share (ttm)6.00
Quarterly revenue growth (yoy)-10.20%
Gross profit (ttm)N/A
EBITDA 158.81M
Net income avi to common (ttm)-14.48M
Diluted EPS (ttm)-0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)572.23M
Total cash per share (mrq)3.45
Total debt (mrq)929.49M
Total debt/equity (mrq)61.56%
Current ratio (mrq)1.60
Book value per share (mrq)9.10

Cash flow statement

Operating cash flow (ttm)63.82M
Levered free cash flow (ttm)-311.08M